Refine my results

Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup phase III BIG 02-98 trial

Pestalozzi, B. C. ; Francis, P. ; Quinaux, E. ; Dolci, S. ; Azambuja, E. ; Gelber, R. D. ; Viale, G. ; Balil, A. ; Andersson, M. ; Nordenskjöld, B. ; Gnant, M. ; Gutierrez, J. ; Láng, I. ; Crown, J. P. A. ; Piccart-Gebhart, M.

In: Annals of Oncology, 2008, vol. 19, no. 11, p. 1837-1841